Author:
Jacobson Stanley,Marcus Elliott M.
Reference34 articles.
1. Cooper, J. R., Bloom, F. E., and Roth, R. H. 1991.The Biochemical Basis of Neuropharmacology. New York. Oxford University Press. (See in particular Chapter 10: Dopamine pp.285–337).
2. Riley, D. E. and A. E. Lang. 2000. Movement disorders. (in) Bradley, W. G., R. B. Daroff, G. M. Fenichel and C. D. Marsden. Neurology in Clinical Practice. Boston, Butterworth Heinemann. II: 1889–1930.
3. Albin, R. I., Young,A. B., Penney,J.B., et al. 1990. Abnormalities of Striatal Projection Neurons And N-Methyl D-Aspartate Receptors in Presymptomatic Huntington’s Disease. N. Engl. J. Med.322:1293–1298.
4. Aziz.T.Z., Peggs.D., Sambrook.M.A., and Crossman.A.R. 1991. Lesion Of the Subthalamic Nucleus for the Alleviation of l-Methyl-4 Phenyl 1,2,3,6, Tetrahydropyridine (MPTP) Induced Parkinsonism In the Primate. Movement Disorders. 6:288–292.
5. Ballard, P.H., Tetrud, J.W., and Langston, J.W. 1985.Permanent Human parkinsonism due to l-methyl-4 phenyl, 1,2,3,6, tetra-Hydropyrine (mptp): seven cases. Neurology, 35:949–56.